School of Medicine


Showing 1-10 of 10 Results

  • Michael Lange

    Michael Lange

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Surgery - General Surgery

    BioUndergrad: Brigham Young University
    Medical School: Indiana University School of Medicine
    Medical Internship: General Surgery, Stanford Health Care

  • Byrne Lee, MD FACS

    Byrne Lee, MD FACS

    Clinical Professor, Surgery - General Surgery

    BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.

    Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.

    Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.

  • Yen-Chung Andrew Lee

    Yen-Chung Andrew Lee

    Clinical Assistant Professor (Affiliated), Surgery - General Surgery

    BioDr. Yen-Chung Andrew Lee is a board certified surgeon who practices General and Bariatric Surgery in Pleasanton. He completed a fellowship in Advanced Laparoscopic Surgery at Brown University.

    Dr. Lee's personal interests include golfing, fishing, cars, drawing, and playing violin.

  • April Leyson

    April Leyson

    Section Administrative Supervisor, Surgery - General Surgery

    Current Role at StanfordAdministrative Associate
    For Drs. Dan E. Azagury, Byrne Lee, Carolyn Seib, and Dr. George Poultsides
    Stanford Department of Surgery
    Section of Bariatric and Minimally Invasive Surgery
    & Section of Surgical Oncology

  • Cara A. Liebert, MD, FACS

    Cara A. Liebert, MD, FACS

    Clinical Assistant Professor, Surgery - General Surgery

    Current Research and Scholarly InterestsCurrent research interests include Surgical Education and Minimally Invasive Surgery. Primary research focus is the development, implementation, and collection of validity evidence for ENTRUST, an online virtual patient simulation platform for assessment of clinical decision-making.

  • Dana Lin, MD

    Dana Lin, MD

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital.

    Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers. She is skilled in mini-incision, minimally invasive (laparoscopic), and remote access (scarless endoscopic) surgery as well as lymph node dissection for cancer. She currently serves as Director of the Parathyroid Center within the Endocrine Oncology Program at Stanford.

    Dr. Lin strives to deliver expert surgical care to patients with utmost humanism and compassion. She considers it a privilege and joy to be entrusted as one’s surgeon and is committed to ensuring the best clinical and cosmetic outcome for each of her patients. Dr. Lin welcomes patients at Stanford Cancer Center in Palo Alto as well as Stanford Health Care in Emeryville and Pleasanton (ValleyCare).

  • Yi Liu

    Yi Liu

    Postdoctoral Scholar, General Surgery

    BioDr. Liu is a postdoc fellow at Stanford University School of Medicine. She is also a Chinese board-certificated, fellowship-trained clinician with demonstrated clinical and research expertise in Critical Care Medicine and interdisciplinary studies of nanomedicine.

    She received her residency and fellowship training (Emergency Medicine & Intensive Care Medicine) at Chongqing Medical University (China) and sub-internship in Sorbonne Université (Pitié-Salpêtrière Hospital, Paris, France) and Tiantan Hospital (Beijing, China). In addition to her MD degree, She undertook PhD training in nanomedicine for cancer/infectious disease early detection and to identify potential new treatments for severe infectious/cancer patients. Her postdoctoral training in nano-enabled therapeutic at Stanford has helped advance her knowledge of how nanotechnology improve the application of nanomedicine in early diagnosis of diseases. She has published numerous articles on a wide range of nanoplatforms-related topics. She has also received several academic and teaching awards related to clinical skills and research on molecular imaging.

  • Daphne P. Ly, MD, FACS

    Daphne P. Ly, MD, FACS

    Affiliate

    Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
    2. Apply Cancer Genetics in cancer treatment and cancer risk reduction.